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Abstract 
Background: Nanoparticles can be used for targeted drug delivery, in particular for brain cancer therapy. However, 
this requires a detailed analysis of nanoparticles from the associated microvasculature to the tumor, not easy because 
of the required high spatial resolution. The objective of this study is to demonstrate an experimental solution of this 
problem, based in vivo and post‑mortem whole organ imaging plus nanoscale 3‑dimensional (3D) X‑ray microscopy.
Results: The use of gold nanoparticles (AuNPs) as contrast agents paved the way to a detailed high‑resolution three 
dimensional (3D) X‑ray and fluorescence imaging analysis of the relation between xenografted glioma cells and the 
tumor‑induced angiogenic microvasculature. The images of the angiogenic microvessels revealed nanoparticle leak‑
age. Complementary tests showed that after endocytotic internalization fluorescent AuNPs allow the visible‑light 
detection of cells.
Conclusions: AuNP‑loading of cells could be extended from the case presented here to other imaging techniques. 
In our study, they enabled us to (1) identify primary glioma cells at inoculation sites in mice brains; (2) follow the sub‑
sequent development of gliomas. (3) Detect the full details of the tumor‑related microvasculature; (4) Finding leakage 
of AuNPs from the tumor‑related vasculature, in contrast to no leakage from normal vasculature.
© 2015 Lai et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://
creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided 
you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate 
if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/
zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Along the path towards the potential use of nanoparticles 
as drug carriers for cancer therapy and diagnosis [1–3], 
some critical issues are related to the tumor-microvascu-
lature leakage of nanoparticles [4–6]. This leakage could 
notably impact drug carrying nanotechnologies [7–10]. 
Observing nanoparticle leakage, however, is a challenge 
for most imaging methods. The objective of our study 
was to practically demonstrate a solution to this problem 
in the specific case of glioma tumors, one of highest mor-
tality rate and difficult to treat cancers. Glioma is also one 
type of tumor expresses high level of angiogenesis [11].
In a broader picture, the above problem is related to the 
issue of the BBB (blood brain barrier) breakdown [12, 13]. 
A protective mechanism for non-reproducible neurons 
from most macromolecules, BBB also impedes the deliv-
ery of therapeutic agents to specific region of the brain 
and therefore is an obstacle in the treatments of many 
brain disorders. In the case of brain tumor treatment, BBB 
is not always intact due to the abnormal structure of the 
vascular endothelial cells and the associated pericytes: 
this could create therapeutic opportunities [14–16].
However, many questions about the corresponding 
mechanisms remain to be clarified by suitable experi-
ments. This creates the need for new imaging approaches 
that should complement well-established techniques 
such as immunochemical methods, e.g., anti-IgG immu-
nohistology [17, 18]. Ideally, the new approaches should 
detect all the details of the leakage of nanoparticles from 
the microvasculature into the surrounding tumor tissues.
This requires simultaneous imaging of angiogenesis 
vessels and nanoparticles. Furthermore, the imaging 
should be in 3D to link the particles outside the ves-
sels with the vessel leakage. Tumor angiogenesis vessels 
were previously detected with techniques such as mag-
netic resonance imaging (MRI) [19, 20] and ultrasound 
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imaging [21], whose resolution, however, does not dis-
tinguish perfused nanoparticles from those leaked from 
angiogenic blood vessels.
X-ray imaging is a natural candidate for this task, since 
recent progress brought it close to nanometer-level 
resolution; furthermore, it was successfully tested for 
complete profiling of the tumor angiogenesis microvas-
culature [22]. Our objective here is to practically demon-
strate its use to detect nanoparticle leakage.
Results and discussion
Our study is based on multiple non-conventional imag-
ing techniques: phase contrast microradiology [23, 24], 
transmission X-ray microscopy (TXM) [25–29] and vis-
ible fluorescent nanoparticle imaging. The correspond-
ing performances were augmented by gold nanoparticles 
(AuNPs), which were already used for X-ray contrast 
enhancement [22, 30–34].
We investigated both bare and 11-MUA-coated AuNPs 
(MUA = mercapto − undecanoicacid). Note that AuNPs 
become photoluminescent at very small sizes, creating 
the opportunity to combine X-ray imaging with fluores-
cent microscopy [35–37]—a strategy that is part of our 
present work.
This combined approach included two different appli-
cations: first, after loading large AuNP amounts in glioma 
cells and inoculating them, we traced the tumor develop-
ment. Specifically, we could detect and analyze the cor-
responding anomalous microvasculature, down to very 
small (a few µm) vessels. Second, we could study the leak-
age of AuNPs from microvessels using in parallel both 
X-ray microscopy and fluorescence microscopy.
Our experiments were based on large loads of AuNPs 
in glioma cells, up to >50  pg/cell. We had previously 
found that large amounts of AuNPs can be internalized in 
cells via endocytosis without affecting their viability [38–
42]. In the present case, we observed that the AuNPs, 
even at our highest load levels, do not affect the prolif-
eration and other functions of glioma cells. They do pro-
vide, however, the required X-ray contrast enhancement 
for detailed monitoring of the tumor growth. We could 
thus specifically analyze the relation between the primary 
inoculated cancer cells, their proliferation and the subse-
quent tumor growth and metastasis.
The tumor-related microvasculature is of course a cru-
cial issue in this analysis. For this, in addition to AuNPs, 
we also used as contrast agent high-density BaSO4 nano-
particle colloid, following in both cases the nanoparticle 
flow in the blood system [22]. The analysis of microvas-
culature was also performed in 3D by X-ray microtomog-
raphy, reaching ~1 µm spatial resolution.
The X-ray imaging methods included in specific cases 
20  nm resolution TXM [25–29], reaching ~20  nm 
resolution. In the analysis of features of particular inter-
est this revealed, for example, individual cells adhering to 
the vessel walls away from the inoculation site—indicat-
ing migration along the vessel system.
Prior to the imaging experiments, we performed viabil-
ity tests. In general, the cell survival rate was higher after 
exposure to bare AuNPs than to MUA-AuNPs. The con-
centration of bare AuNPs reached 2  mM without inter-
fering with the cell viability (Additional file 1: Figure S1a), 
whereas effects were detected at 0.5  mM concentration 
in the case of MUA-AuNPs. Furthermore, we found that 
the GBM8401 cell line is less tolerant than the U87 cell 
line, with detectable viability effects at a concentration of 
0.5 mM (Additional file 1: Figure S1b).
Optical microscopy images revealed large amount of 
bare AuNPs in the U87 cells (Additional file 1: Figure S1c, 
first row). On the contrary, the uptake of bare AuNPs 
in GBM8401 was relative low and the cell morphology 
appeared altered (Additional file 1: Figure S1c, second row).
Fluorescence images of U87 cells loaded with MUA-
AuNPs exhibited bright areas revealing a high amount 
of internalized nanoparticles. TEM images and histopa-
thology optical micrographs confirmed the internaliza-
tion of bare AuNPs and MUA-AuNPs (Additional file 1: 
Figure S2).
The initial part of our study used microresolution 
radiography with bare AuNPs as biomarkers to localize 
in vivo tumor cells in the brain. In addition, fluorescence 
microscopy tests used MUA-AuNPs. We observed tumor 
cells growing into gliomas without interference from the 
AuNPs.
The perfused cells are visible as black dots along the 
injection needle paths in the radiographs of Fig. 1. We see 
here two examples (Fig. 1a, b) of projection images each 
with two different viewing directions; complete tomogra-
phy reconstruction to reveal the detailed 3D tumor micro-
environment. Most tumor cells near the injection site are 
found on the surfaces of small vessels (Fig. 2). In Fig. 2a, b, 
such vessels correspond to the central dark grey area and 
the tumor cells are the black dots in the brain tissue.
The reconstructed tomographic images of Figs  2d–g 
correspond to the marked region in Fig.  2b, and reveal 
that the primary tumor cells did not invade the vessels 
besides adhering to their surfaces. TEM did confirm the 
presence of tumor cells with bare AuNPs (Additional 
file 1: Figure S3).
Fluorescent micrographs of UV-stimulated MUA-
AuNP specimens confirmed the above results. Further-
more, they also revealed gliomas in the brain caused by 
the injected cells. Figure  3 shows primary tumor cells 
in brain tumor tissues; TEM images (Additional file  1: 
Figure  S4) and histopathology micrographs (Additional 
file 1: Figure S2d) corroborate these observations.
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Finally, we would like to focus on the key result of our 
study: the leakage of nanoparticles from the microvas-
culature into the tumor tissue. Typical results are shown 
in Fig.  4. There we see high-resolution TXM images 
and corresponding tomographic reconstructions. Such 
images clearly reveal the leakage of AuNPs—specifically, 
bare nanoparticles. More specifically, leakage is observed 
for the tumor areas, whereas we detect no leakage out of 
vessels in the areas of healthy brain tissues (Fig. 5). To the 
best of our knowledge, this is the first direct imaging of 
the leakage of metal nanoparticles to tumors in the brain.
We did not find any major limitations in the use of 
our approach, in particular in the multiple advantages of 
inoculating AuNPs-loaded cancer cells. This raises the 
question of the potential applications of this approach to 
other imaging techniques. The key problem is to reach a 
sufficient concentration without affecting the cancer cell 
activity. AuNPs are ideal for that because of their high 
biocompatibility: they could be used for imaging tech-
niques such as infrared spectromicroscopy [11] that can 
easily detect them over the background. AuNPs based on 
gold radioisotopes could assist techniques such as Single 
Photon Emission Computer Tomography (SPECT) [43], 
Fig. 1 Projection x‑ray images of tumor cells loaded with bare AuNPs 
in the brain, from two examples (a and b) each of two different 
points of views: anteroposterior and lateral. The black dots corre‑
spond to tumor cells
Fig. 2 TXM micrographs of AuNP loaded U87 cells in brain tissues. TXM micrographs of bare AuNPs in U87 cells in brain tissues. The dark grey 
regions outline small vessels, whereas the black dots correspond to bare AuNPs, which are internalized by the U87 cells. a Patchwork of projection 
images on a region showing a microvessel with U87 cells that adhere to its wall, b individual projection image, c 3D tomographic reconstructed 
image and d–g tomographic reconstructed images of slices; the internal vessels are below the yellow line. Cells with bare AuNPs are seen on the 
surface of vessels (above the yellow lines)
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again taking advantage of the biocompatibility and high 
loading levels.
For medical imaging techniques such as MRI [40, 44], 
positron emission tomography (PET) [45], SPECT [46], 
computed tomography (CT) [34] and ultrasound imag-
ing [21], many different nanoparticles were reported to 
enhance the sensitivity. Along this line, nanoparticles can 
be loaded into cancer cells for detection in vivo in animal 
models. In vivo imaging is not likely to reach the resolu-
tion required to detect single cells, but can identify tumor 
locations and possibly metastasis.
The high resolution achieved with X-ray microscopy 
is critical for the detection of nanoparticle leakage, par-
ticularly at the early stage of the BBB breakdown. The 
low concentration of nanoparticles leaking from blood 
vessels could limit the applications to animal models 
and in general to drug delivery. However, it should still 
be possible to use nanoparticles as contrast agents for the 
detection of the location and outline of tumors in medi-
cal diagnostics. Furthermore, suitable nanoparticle modi-
fications could allow the in vivo detection of leakage for 
diagnostics.
Conclusions
These are the main results of our study: first, by loading 
glioma cells with high concentrations of bare AuNPs or 
MUA-AuNPs we made them detectable by X-ray and 
fluorescence imaging. Second, we could thus identify 
primary glioma cells at inoculation sites in mice brains. 
Third, we could then follow the subsequent development 
of gliomas. Fourth, we detected the full details of the 
tumor-related microvasculature. Fifth, we found leakage 
of AuNPs from the tumor-related vasculature, in contrast 
to no leakage from normal vasculature.
The significance of our results goes beyond the mere 
tests of the experimental strategy. By showing that we can 
detect leakage of nanoparticles into brain tumor areas, 
we open the door to a much-needed analysis of a phe-
nomenon of great importance, in particular because of its 
role in nanomedicine therapies for brain diseases.
Methods
Cell viability tests
U87 and GBM8401 glioma cell lines were incubated with 
Dulbecco’s Modified Eagle’s Medium (DMEM)/10 % fetal 
bovine serum (FBS) and cultured at 37 C in humid air 
with 5 % CO2. U87 and GBM8401 glioma cell lines were 
separately co-cultured with 0, 0.5, 1, 1.5 and 2 mm of bare 
Au NPs and MUA-Au NPs for 24 h to test the viability—
which was quantitatively assessed by counting the num-
ber of living cells using the ADAM cell counter (BioAssay 
Systems, Hayward, CA, USA). The nanoparticle prepara-
tion is described, for example, in Ref. [47, 48].
In vivo orthotopic xenografting
All procedures involving experimental animals in this 
work were approved by the Academia Sinica Institutional 
Animal Care and Utilization Committee (AS IACUC). 
BALB/cAnNCg-Foxn1nu/CrlNarl nude mice were pur-
chased from the National Laboratory Animal Center, 
Fig. 3 Optical images of entire brain with MUA‑AuNPs. Optical images of the entire brain reveal tumor cells with fluorescent MUA‑AuNPs. The 
images on the left‑hand side were taken under normal illumination and show no fluorescence. The right‑hand images were taken under UV light 
exposure and reveal the nanoparticle fluorescence
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Taiwan. The mice were housed in individual ventilated 
cages (five per cage) with wood chip bedding and kept 
at 24 ± 2  °C with a humidity of 40–70 % and a 12-hour 
light/dark cycle.
U87 glioma cell lines were co-cultured with 2 mm bare-
AuNPs or 0.5 µm MUA-AuNPs for 24 h. The method for 
in vivo orthotopic xenografting was previously described 
[42, 49]. In brief, cells were harvested and re-suspended 
in PBS. A total of 5 × 105 U87 cells in 5 μl PBS-contain-
ing glioma cells suspension solution were inoculated via 
a 32 gauge needle (injection rate 1 μl per min) into the 
basal ganglia of the right brain hemisphere. Tumor imag-
ing started after either 7 or 14 days.
Contrast agent perfusion for microvessel imaging
After a midline neck incision, the right common carotid 
artery (CCA) was isolated and a small incision was made. 
A catheter (PE-08, BB31695, Scientific Commodities, 
Inc., ID 0.2 mm, OD 0.36 mm) was inserted through it. 
6–0 silk sutures were tightly tied around the vessel. The 
tubing was secured with two knots around the CCA and 
then perfused with 500 µL heparinized (500 U/mL) bare-
AuNPs (1.57 mg/mL concentration).
In vivo X‑ray imaging
Microradiology was implemented with unmonochro-
matized (white) synchrotron X-rays emitted by the 01-A 
beamline wavelength shifter of the National Synchrotron 
Radiation Research Center (Taiwan). The photon energy 
ranged from 4–30 keV with a peak intensity at ~12 keV; 
the beam current was kept constant at 360 mA with the 
top-up operation mode.
We obtained 4.5  ×  3.4  mm2 radiographs by con-
verting the X-rays into visible light using a CdWO4 
single crystal scintillator and then detecting the 
photons with an optical microscope equipped with 
a 1600  ×  1200 pixel CCD camera (model 211, Diag-
nostic Instruments). We reduced the radiation dose by 
Fig. 4 X‑ray micrographs show leakage of AuNPs out of vessels. X‑ray micrographs show bare AuNPs leaking out of vessels in the proximity of brain 
tumors. a The projection X‑ray images at two different magnifications of a U87 mouse brain tumor with bare AuNPs perfusion show the whole brain 
vasculature, b patchwork of TXM images; c, d individual TXM projection images taken at different angles, corresponding to the light-grey rectangle 
in (b); e, f 3D tomographic reconstructed images, corresponding to the (c, d) images; g, h tomographic reconstructed single‑slice images of (e, f). 
The yellow arrowheads mark bare AuNPs leaking out of tumor vessels. The white arrows mark the nuclei of endothelial cells
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attenuating the X-ray beam with two 550  µm silicon 
wafers.
The typical exposure time was ~100  ms with and the 
dosage 33.9  Gy. The sample-scintillator distance was 
5  cm. We used a 2 ×  lens in the optical microscope to 
obtain the desired field of view; the pixel size in the final 
image was 2.8 × 2.8 µm2.
Tissue sample preparation
After developing glioma, the mice were sacrificed by an 
overdose of Zoletil 50 (50  mg/kg; Virbac Laboratories, 
Carros, France) administered by intramuscular injection 
(weight ~20–25 g). Brain tissue specimens were immersed 
in 3.7 % paraformaldehyde for 24 h. After fixation, the tis-
sues were washed by PBS (phosphate buffer solution) three 
times for 1  h. Before embedding, the tissues were sepa-
rated in two groups, one for X-ray imaging (and in some 
cases fluorescence microscopy) with micron-level resolu-
tion and the other for nanoresolution X-ray microscopy.
Microresolution X-ray imaging was performed on 
fresh thick tissue specimens in 3.7 % paraformaldehyde. 
Nanoresolution imaging was performed instead on speci-
mens embedded in paraffin. Before being embedded, all 
tissues were dehydrated by sequential immersions in eth-
anol, from low to high concentrations.
The specimens for nanoresolution were sliced to 
30 µm thickness and immersed in Xylene three times for 
5  min, to remove the remaining wax. Then, they were 
dehydrated with the procedure described above and 
immersed in distilled water. The specimens were then 
processed with heavy metal staining (osmium), washed 
with distilled water three times for 5  min, dehydrated 
and embedded in Embed-812 Resin (EMS, Hatfield, PA). 
We also followed this procedure to prepare specimens 
for standard visible microscopy analysis, except that the 
heavy metal staining was replaced by H&E staining.
Tomography
Thick samples in resin were used to take sets of 1000 
images at equal angular distances within 180 degrees. 
The exposure time was 100  ms per image, correspond-
ing to a 33.9  Gy dose. The tomographic reconstruction 
was performed with the IDL software. All reconstructed 
images were processed with the Amira software to obtain 
3D renditions.
X‑ray microscopy with nanoscale resolution
These tests were performed on the 32-ID microscopy 
beamline of the advanced photon source (APS) at the 
Argonne National Laboratory. Our full-field TXM there 
uses a set of capillary condensers to precisely illuminate 
the object with a variable numerical aperture adjusted 
to match the specific FZP objective. The condensers are 
elliptically shaped glass capillaries. The inner diameter of 
0.9 mm was chosen to maximize the vertical acceptance 
of the APS undulator beam at 65 m from the source.
Fig. 5 TXM micrographs show no leakage of AuNPs of normal brain vessels. TXM images of bare AuNPs in normal brain vessels. a Patchwork of 
projection images; b, c individual projection images taken at different angles; d, e 3D tomographic reconstructed images, corresponding to (b, c) 
and (f, g) tomographic reconstructed single‑slice images of (d, e). Yellow arrowheads mark the nuclei of brain cells. White arrows mark the nuclei of 
endothelial cells
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The estimated monochromatic X-ray flux through a Si 
(111) double crystal monochromator focused by the con-
denser was 2 × 1011 photons/s at 8 keV. The high bright-
ness of the APS and the optimized condensers design 
yielded an excellent imaging rate of 50 ms/frame with ~1 × 
104 CCD counts per pixel. We systematically implemented 
phase contrast imaging using with an Au Zernike phase 
ring placed at the back focal plane of the FZP objective.
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Additional file
Additional file 1: Figure S1. Cell viability analysis. U87 and GBM8401 
glioma cell lines were separately co‑cultured with 0, 0.5, 1, 1.5 and 2 
mM of bare Au NPs (a) and MUA‑Au NPs (b) for 24 hr, U87 and GM18401 
cell lines showed a good biocompatibility of bare‑AuNPs. However, the 
biocompatibility was slightly lower for MUA‑AuNPs than for bare‑AuNPs. 
(c) Optical images of bare AuNPs co‑cultured with U87 and GBM 8401 cell 
lines. The optical images and fluorescence imaging of MUA‑AuNPs co‑cul‑
tured with U87 (d), and GBM 8401 (e) cell lines. Figure S2. Transmission 
electron microscope images of U87 cell in different conditions. (a) Control 
specimen, without any treatment. (b) and (c) Bare AuNPs MUA‑AuNPs 
co‑cultured with cells. (d) In vivo cellular tracking U87 glioma cells loaded 
with bare AuNPs demonstrated invasive glioma cells in brain. Figure S3. 
Transmission electron microscope images of tumor cells with bare‑AuNPs 
in brain tumor tissue. Scale bars: 1 μm. Figure S4. Transmission electron 
microscope images of tumor cells with MUA‑AuNPs in brain tumor tissue. 
Scale bars: 0.5 μm.
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